Results overview: Found 48 records in 0.02 seconds.
Articles, 33 records found
Research literature, 12 records found
Personal and institutional archives, 3 records found
Articles 33 records found  1 - 10nextend  jump to record:
7 p, 879.9 KB Rupatadine oral solution for 2-5-year-old children with allergic rhinitis : a safety, open-label, prospective study / Santamaría, Eva (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Izquierdo, Iñaki (Clinical Development, R&D, J. Uriach y Compañía, S.A., Barcelona, Spain) ; Valle, Marta (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Vermeulen, Jan (Allergic Department, Parow Research, Cape Town, South Africa) ; Potter, Paul (Allergy Diagnostic and Clinical Research Unit, Department of Medicine, University of Cape Town Lung Institute, Cape Town, South Africa)
There are few clinical trials that assess the efficacy of antihistamines in very young children. Rupatadine is a second-generation antihistamine indicated for the treatment of allergic rhinitis (AR) and urticaria. [...]
2018 - 10.2147/JAA.S164632
Journal of Asthma and Allergy, Vol. 11 (september 2018) , p. 225-231  
18 p, 504.6 KB Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure / Armstrong, April (Keck School of Medicine of the University of Southern California. Department of Clinical Research) ; Paul, Carle (Paul Sabatier University. Dermatology Department, Toulouse University Hospital (CHU)) ; Puig, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Boehncke, Wolf Henning (University of Geneva. Department of Pathology and Immunology) ; Freeman, Michael (The Skin Centre, Benowa, QLD Australia) ; Torii, Hideshi (Tokyo Yamate Medical Center. Division of Dermatology) ; Papp, Kim (K Papp Clinical Research and Probity Medical Research) ; Griffiths, Christopher E. M. (NIHR Manchester Biomedical Research Centre. Dermatology Centre, Salford Royal Hospital, University of Manchester) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Reich, Kristian (Skinflammation® Center, Hamburg, Germany) ; Gooderham, Melinda (Centre for Dermatology and Probity Medical Research, Peterborough, ON Canada) ; Terui, Tadashi (Nihon University School of Medicine. Department of Dermatology) ; Renda, Lisa (Eli Lilly and Company) ; Agada, Noah (Eli Lilly and Company) ; Xu, Wen (Eli Lilly and Company) ; Gallo, Gaia (Eli Lilly and Company) ; Lebwohl, Mark G. (Icahn School of Medicine at Mount Sinai. Department of Dermatology) ; Universitat Autònoma de Barcelona
Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the treatment of moderate-to-severe plaque psoriasis. We examined the safety and tolerability of up to 5 years of ixekizumab therapy in patients with psoriasis. [...]
2019 - 10.1007/s13555-019-00340-3
Dermatology and Therapy, Vol. 10 (november 2019) , p. 133-150  
13 p, 629.0 KB Hospital survey on patient safety culture (HSOPSC) : a multi-method approach for target-language instrument translation, adaptation, and validation to improve the equivalence of meaning for cross-cultural research / Palmieri, Patrick A. (Universidad Norbert Wiener. EBHC South America: A Joanna Briggs Institute Affiliated Group) ; Leyva-Moral, Juan M. (Universitat Autònoma de Barcelona. Departament d'Infermeria) ; Camacho-Rodriguez, Doriam E. (Universidad Cooperativa de Colombia. School of Nursing) ; Granel-Gimenez, Nina (Universitat Autònoma de Barcelona. Departament d'Infermeria) ; Ford, Eric W. (University of Alabama at Birmingham, Ryals Public Health Building. School of Public Health) ; Mathieson, Kathleen M. (A. T. Still University. College of Graduate Health Studies) ; Leafman, Joan S. (A. T. Still University. College of Graduate Health Studies)
The Hospital Survey on Patient Safety Culture (HSOPSC) is widely utilized in multiple languages across the world. Despite culture and language variations, research studies from Latin America use the Spanish language HSOPSC validated for Spain and the United States. [...]
2020 - 10.1186/s12912-020-00419-9
BMC Nursing, Vol. 19 (april 2020)  
11 p, 1.6 MB Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 / Eron, J.J. (University of North Carolina School of Medicine) ; Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ; Cunningham, D. (Pueblo Family Physicians) ; Pulido, F. (Medicina Interna. Hospital General Universitario de Alicante) ; Post, F. (King's College Hospital NHS Foundation Trust) ; De Wit, S. (Saint-Pierre University Hospital. Université Libre de Bruxelles) ; Lathouwers, E. (Janssen Pharmaceutica NV) ; Hufkens, V. (Janssen Pharmaceutica NV) ; Jezorwski, J. (Janssen Research & Development) ; Petrovic, R. (Janssen Pharmaceutica NV) ; Brown, K. (Janssen Pharmaceutica NV) ; Van Landuyt, E. (Janssen Pharmaceutica NV) ; Opsomer, M. (Janssen Pharmaceutica NV) ; De Wit, S. (Saint-Pierre University Hospital. Université Libre de Bruxelles) ; Florence, E. (Institute of Tropical Medicine) ; Moutschen, M. (Infectious Diseases department. Liège University Hospital) ; Van Wijngaerden, E. (Department of General Internal Medicine. University Hospitals. KU Leuven - University of Leuven) ; Vandekerckhove, L. (Ghent University and Ghent University Hospital) ; Vandercam, B. (AIDS Reference center. Cliniques Universitaires Saint-Luc) ; Brunetta, J. (Maple Leaf Medical Clinic) ; Conway, B. (Vancouver Infectious Diseases Center) ; Klein, M. (Division of Infectious Diseases. Faculty of Medicine. McGill University Health Centre) ; Murphy, D. (Institut national de santé publique du Québec) ; Rachlis, A. (Sunnybrook Health Sciences Centre) ; Shafran, S. (Department of Medicine. University of Alberta) ; Walmsley, S. (University Health Network) ; Ajana, F. (Infectious Diseases Department. Tourcoing Hospital) ; Cotte, L. (Hospices Civils de Lyon. Hôpital de la Croix-Rousse) ; Girardy, P.M. (University Pierre & Marie Curie) ; Katlama, C. (HIV Clinical Research Unit) ; Molina, J.M. (Department of Infectious Diseases. St-Louis Hospital APHP. University of Paris Diderot) ; Poizot-Martin, I. (Clinical Immuno-Hematology Department. Aix-Marseille University. Sainte-Marguerite University Hospital and Inserm U912) ; Raffi, F. (CHU Hôtel Dieu) ; Rey, D. (Le Trait d'Union. HIV-Infection Care Center. Hôpitaux Universitaires de Strasbourg) ; Reynes, J. (Montpellier University Hospital) ; Teicher, E. (Infectious Diseases Department. APHP. Hôpital Bicêtre) ; Yazdanpanah, Y. ; Gasiorowski, J. (Independent Laboratory for Monitoring Infections among Drug Users at the Department of Infectious Diseases. Liver Disease and Acquired Immune Deficiencies. Wroclaw Medical University) ; Halota, W. (Department of Infectious Diseases and Hepatology. Nicolaus Copernicus University) ; Horban, A. (Medical University of Warsaw. Department for Adult's Infectious Diseases) ; Piekarska, A. (Department of Infectious Diseases and Hepatology. Medical University of Lodz) ; Witor, A. (Regional Hospital. Out-Patient's Clinic for Immune Deficiency) ; Arribas, J.R. (Hospital Universitario La Paz. IdiPAZ) ; Perez-Valero, I. (Department of La Paz Hospital) ; Berenguer, J. (Hospital General Universitario Gregorio Marañón) ; Casado, J. (Department of Infectious Diseases. Ramon y Cajal Hospital) ; Gatell, J.M. (Infectious Diseases Department. HCB) ; Gutiérrez, Félix (Infectious Diseases Unit. Hospital Universitario de Elche) ; Galindo, M.J. (Hospital Clínico Universitario de Valencia) ; Gutiérrez Macià, Mª Del Mar (Institut d'Investigació Biomèdica Sant Pau) ; Iribarren, J.A. (Hospital Universitario Donostia) ; Knobel, H. (Hospital del Mar (Barcelona)) ; Negredo, E. (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Pineda, J.A. (Unit of Infectious Diseases and Microbiology. Hospital Universitario de Valme) ; Podzamczer, D. (dIDIBELL-Hospital Universitari de Bellvitge. L'Hospitalet) ; Sogorb, J.P. (HIV Unit. Hospital 12 de Octubre. imas12. UCM) ; Pulido, F. (Medicina Interna. Hospital General Universitario de Alicante) ; Ricart, C. (Department of Microbiology. School of Medicine. University of Valencia) ; Rivero, A. (Infectious Diseases Unit. Hospital Universitario Reina Sofía. Instituto Maimonides de Investigación Biomedica de Córdoba IMIBIC Cordoba University) ; Santos Gil, I. (Unidad de Enfermedades Infecciosas. Hospital Universitario de la Princesa) ; Blaxhult, A. (Department of Infectious Diseases. Venhälsan. Södersjukhuset) ; Flamholc, L. (Department of Infectious Diseases. Malmö University Hospital) ; Gisslèn, M. (Department of Infectious Diseases. University of Gothenburg) ; Thalme, A. (Department of Infectious Diseases. Karolinska University Hospital) ; Fehr, J. (Division of Infectious Diseases and Hospital Epidemiology. University Hospital Zurich) ; Rauch, A. (Department of Infectious Diseases. Bern University Hospital Inselspital. University of Bern) ; Stoeckle, M. (Division of Infectious Diseases and Hospital Epidemiology. Departments of Medicine and Clinical Research. University Hospital of Basel and University of Basel) ; Clarke, A. (Claude Nicol Centre. Royal Sussex County Hospital. Brighton and Sussex University Hospitals NHS Trust) ; Gazzard, B.G. (St. Stephen's Centre. Department of HIV/Genito-Urinary Medicine. Chelsea and Westminster Hospital) ; Johnson, M.A. (Queen Mary University) ; Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ; Post, F. (King's College Hospital NHS Foundation Trust) ; Ustianowski, A. (Regional Infectious Diseases Unit. North Manchester General Hospital) ; Waters, L. (University College London Hospital) ; Bailey, J. (Department of Medicine. Johns Hopkins University School of Medicine) ; Benson, P. (Be Well Medical) ; Bhatti, L. (AIDS Healthcare Foundation) ; Brar, I. (Henry Ford Hospital) ; Bredeek, U.F. (Metropolis Medical PC) ; Brinson, C. (Central Texas Clinical Research) ; Crofoot, G. (The Crofoot Research Center) ; Cunningham, D. (Pueblo Family Physicians) ; DeJesus, E. (Pueblo Family Physicians) ; Dietz, C. (Orlando Immunology Center) ; Dretler, R. (HIV Medicine. Kansas City Free Health Clinic) ; Eron, J. (Infectious Disease Specialists of Atlanta) ; Felizarta, F. (Private Practice) ; Fichtenbaum, C. (University of Cincinnati College of Medicine) ; Gallant, J. (Southwest CARE Center) ; Gathe, J. (Therapeutic Concepts) ; Hagins, D. (Georgia Department of Public Health. Chatham Care Center) ; Henn, S. (Whitman-Walker Health) ; Henry, W.K. (Department of Medicine. University of Minnesota Washington University School of Medicine) ; Huhn, G. (Ruth M. Rothstein CORE Center) ; Jain, M. (Department of Internal Medicine. University of Texas Southwestern Medical Center) ; Lucasti, C. (South Jersey Infectious Disease) ; Martorell, C. (Infectious Disease and The Research Institute) ; McDonald, C. (Tarrant County Infectious Disease Associates) ; Mills, A. (Southern California Men's Medical Group) ; Morales-Ramirez, J. (Clinical Research Puerto Rico Inc.) ; Mounzer, K. (Philadelphia FIGHT) ; Nahass, R. (ID Care) ; Olivet, H. (Community Research Initiative of New England) ; Osiyemi, O. (Triple O Research Institute PA) ; Prelutsky, D. (Department of Internal Medicine. Washington University School of Medicine) ; Ramgopal, M. (Midway Immunology Center. Fort Pierce) ; Rashbaum, B. (Capital Medical Associates) ; Richmond, G. (Broward General Medical Center) ; Ruane, P. (Ruane Clinical Research Group) ; Scarsella, A. (Pacific Oaks Medical Group) ; Scribner, A. (DCOL Center for Clinical Research) ; Shalit, P. (Peter Shalit MD and Associates) ; Shamblaw, D. (La Playa Medical Group) ; Slim, J. (Department of Infectious Diseases. Seton Hall University) ; Tashima, K. (The Miriam Hospital. Warren Alpert Medical School of Brown University) ; Voskuhl, G. (AIDS Arms. Inc.) ; Ward, D. (Dupont Circle Physicians Group) ; Wilkin, A. (Wake Forest School of Medicine) ; de Vente, J. (Living Hope Foundation) ; Universitat Autònoma de Barcelona
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. [...]
2019 - 10.1016/j.antiviral.2019.104543
Antiviral Research, Vol. 170 (october 2019) , p. 104543  
Validity of a single antibody-based lateral flow immunoassay depending on graphene oxide for highly sensitive determination of E. coli O157:H7 in minced beef and river water / Hassan, Abdel-Raim H.A. (Institut Català de Nanociència i Nanotecnologia) ; Bergua, José Francisco (Institut Català de Nanociència i Nanotecnologia) ; Morales Narváez, Edén (Biophotonic Nanosensors Laboratory) ; Merkoçi, Arben (Institut Català de Nanociència i Nanotecnologia)
Considering the health risks of E. coli O157:H7 presence in food and water, an affordable and highly sensitive detection method is crucial. Herein, we report the first use of a single antibody-based fluorescent lateral flow immunoassay (FLFIA) depending on non-radiative energy transfer between graphene oxide and quantum dots for determination of E. [...]
2019 - 10.1016/j.foodchem.2019.124965
Food chemistry, Vol. 297 (November 2019) , art. 124965  
7 p, 390.3 KB Dilemas en la enfermedad crónica avanzada : ¿prevención o desprescripción? / Llobet Vila, Laura (Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol) ; Manresa Domínguez, Josep Maria (Universitat Autònoma de Barcelona. Departament de Infermeria) ; Carmona Segado, José Manuel (ABS Sant Llorenç Savall, Institut Català de la Salut) ; Franzi Sisó, Alícia (Unitat de Farmàcia, SAP Vallès Occidental, Institut Català de la Salut) ; Vallès Balasch, Rosa (ABS Castellar del Vallès, Institut Català de la Salut) ; Martínez Díaz, Isabel (ABS Castellar del Vallès, Institut Català de la Salut)
a) Conocer la prescripción preventiva (estatinas, antiagregantes, bifosfonatos, calcio/vitamina D y vitamina B) de los pacientes con patología crónica compleja (PCC) y de los pacientes con enfermedad crónica avanzada (ENCA) y esperanza de vida inferior a 12 meses que fallecieron durante el 2015. [...]
2017 - 10.1016/j.aprim.2017.05.016
Atencion Primaria, Vol. 50 (december 2017) , p. 583-589  
23 p, 346.0 KB Hydropower in the Himalayan hazardscape : strategic ignorance and the production of unequal risk / Huber, Amelie (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
Rapidly expanding hydropower development in areas prone to geological and hydro-climatic hazards poses multiple environmental and technological risks. Yet, so far these have received scant attention in hydropower planning processes, and even in the campaigns of most citizen initiatives contesting these dams. [...]
2019 - 10.3390/w11030414
Water, Vol. 11, issue 3 (March 2019) , art. 414  
10 p, 1.2 MB Safer by design strategies / Cobaleda-Siles, Macarena (Vall d'Hebron Institut de Recerca) ; Guillamon, A.P. (Vall d'Hebron Institut de Recerca) ; Delpivo, Camilla (LEITAT Technological Center) ; Vázquez-Campos, Socorro (LEITAT Technological Center) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia)
Throughout the EU funded FP7 project GUIDENano, we are trying to control and monitor the evolution of nano-enable products during their lifecycle. Small alterations of the nanoparticle (NP) state may have critical consequences on the NP behaviour and performance. [...]
2017 - 10.1088/1742-6596/838/1/012016
Journal of physics, Vol. 838 (2017) , art. 12016  
11 p, 1.9 MB Immunosensing using nanoparticles / De la Escosura Muñiz, Alfredo (Instituto de Nanociencia de Aragón) ; Parolo, Claudio (Institut Català de Nanociència i Nanotecnologia) ; Merkoçi, Arben (Institut Català de Nanociència i Nanotecnologia)
Immunosensing technology is taking advantage of the lastest developments in materials science and inparticular from the nanomaterials field. Because of their unprecedented optical tunability as well as electrical and electrochemical qualities, we are seeing significant developments in the design of novel immunoassays; various conventional optical and electrical platforms which allow for future applications in several fields are being used. [...]
2010 - 10.1016/S1369-7021(10)70125-5
Materials Today, Vol. 13, Issue 7-8 (2010) , p. 24-34  
7 p, 94.8 KB Analysis of laboratory critical values at a referral Spanish tertiary university hospital / Arbiol Roca, Ariadna (Hospital Universitari de Bellvitge) ; Corral Comesaña, Sofía (Synlab Diagnósticos Globales SA) ; Cano Corres, Ruth (Universitat Autònoma de Barcelona) ; Castro Castro, María José (Hospital Universitari de Bellvitge) ; Dastis Arias, Macarena (Hospital Universitari de Bellvitge) ; Dot Bach, Dolors (Hospital Universitari de Bellvitge)
The aim of this study was to analyse critical value data from our laboratory and compare our critical value reporting policy with others in the literature. Analysis of critical values was performed on data obtained over a 6-month period in a tertiary university hospital. [...]
2019 - 10.11613/BM.2019.010704
Biochemia medica, Vol. 29, issue 1 (Feb. 2019) , art. 010704  

Articles : 33 records found   1 - 10nextend  jump to record:
Research literature 12 records found  1 - 10next  jump to record:
53 p, 1.1 MB La importancia del Estado regulador : la repercusión de la alimentación en la salud / Ruiz Gómez, Alba ; Martínez Quirante, Roser, dir. (Universitat Autònoma de Barcelona. Departament de Dret Públic i de Ciències Historicojurídiques) ; Universitat Autònoma de Barcelona. Facultat de Dret
Preservar la salud de los ciudadanos es uno de los objetivos principales de las autoridades de los diferentes países del mundo. Un punto clave para poder llevar esto a cabo es consolidar una correcta legislación en materia de seguridad alimentaria. [...]
Preserving the health of citizens is one of the main objectives of the authorities of the different countries around the world. A key point in order to carry this out is to consolidate a correct legislation on food safety. [...]

Grau en Administració i Direcció d'Empreses i Grau en Dret [994]  
12 p, 416.6 KB El rol de los profesores de formación vial en casos de amaxofobia / Sánchez Marín, Sebastián (Universitat Autònoma de Barcelona. Departament de Pedagogia Aplicada) ; Arnau-Sabatés, Laura (Universitat Autònoma de Barcelona.Departament de Pedagogia Sistemàtica i Social) ; Montané Capdevila, Josep (Universitat Autònoma de Barcelona)
Una buena parte de la población de conductores presenta algún tipo de fobia a conducir, sin embargo, son pocas las intervenciones formativas en el ámbito de la educación y seguridad vial que hasta ahora se han demostrado eficaces para reducirlas. [...]
A good part of the driver population has some type of phobia to drive; however, there are few training interventions in the field of education and road safety that have been shown to be effective in reducing them. [...]

Barcelona, 2020  
408 p, 2.2 MB Las sociedades de clasificación naval. Estatuto jurídico y régimen de responsabilidad / Trius Arias, Julia, autor ; Martínez Jiménez, Ma. Isabel, supervisor acadèmic ; Universitat Autònoma de Barcelona. Departament de Dret Privat
Las sociedades de clasificación naval son entidades dedicadas a la inspección y clasificación de buques de conformidad con una serie de reglas y estándares relativos a la calidad e integridad técnica y estructural de los buques. [...]
Classification societies are entities dedicated to ship classification and inspection in accordance with a series of rules and standards regarding the technical and structural quality and integrity of vessels. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2018  
47 p, 610.9 KB Public Private Partnership management effects on road safety outcomes / Albalate del Sol, Daniel, 1980- (Universitat de Barcelona. Departament d'Econometria Estadística i Economia Aplicada) ; Bel-Piñana, Paula (Universitat de Barcelona. Departament d'Econometria Estadística i Economia Aplicada) ; Xarxa de Referència en Economia Aplicada (XREAP)
Public Private Partnerships (PPP) have become common in providing high-quality infrastructure in many countries worldwide. One of the main reasons for PPP agreements is to improve efficiency and quality in the delivery of public services, as well as to boost investments for expensive projects. [...]
Xarxa de Referència en Economia Aplicada (XREAP) 2017 (XREAP ; 2017/08)  
745 p, 5.9 MB Intervencion democrática y totalitaria del estado en el reconocimiento y el ejercicio del derecho a la seguridad y salud en el trabajo en España / Marín Arce, Juan Ignacio, autor. ; Pons Cànovas, Ferran, supervisor acadèmic (Universitat Autònoma de Barcelona. Departament de Dret Públic i de Ciències Historicojurídiques) ; Universitat Autònoma de Barcelona. Departament de Dret Públic i de Ciències Historicojurídiques
La democracia política tiene su razón de ser en la superación de la desigualdad, objetivo inseparable de la mejora de las condiciones de vida y de trabajo de las mayorías asalariadas. En esta tesis se describe y analiza pormenorizadamente el nacimiento y desarrollo del Derecho del Trabajo en España, cuyas primeras expresiones de entidad abordan precisamente la protección de los trabajadores frente a las lesiones laborales, y el posterior reconocimiento de la necesidad de la intervención del Estado en la relación de trabajo. [...]
Political democracy finds its rationale in overcoming inequalities, together with the inseparable objective of improving salaried worker's life and work conditions. In this thesis, a detailed description and analysis of the origin and development of the Labour Law in Spain is carried out. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2018.  
11 p, 1.2 MB Monitorització de l'activitat física i del moviment per a la seguretat de persones en situació de risc o vulnerabilitat / Manero Hernandez, Cristian ; Pujol Capdevila, Jaume, dir. (Universitat Autònoma de Barcelona. Departament d'Enginyeria de la Informació i de les Comunicacions) ; Universitat Autònoma de Barcelona. Escola d'Enginyeria
La societat ha anant canviant i evolucionant acompanyada de les noves tecnologies. Si mirem el comportament de les persones en l'actualitat i el seu model de vida, i la comparem amb èpoques no tan llunyanes podem apreciar com cada cop més es busquen formes d'ajuda pel desenvolupament quotidià per mitjà de les noves tecnologies, doncs s'han convertit en un element gairebé indispensable per a gran part de la població. [...]
Society has been changing and evolving accompanied by new technologies. Looking at the behavior of people today and their stylelife, and compared with times not so distant as we see increasingly look for ways to help the daily development through new technologies, as it has been became an almost indispensable element for a large part of the population. [...]
La sociedad ha ido cambiando y evolucionando acompañada de nuevas tecnologías. Si miramos el comportamiento de las personas en la actualidad y su modelo de vida, y la comparamos con épocas no tan lejanas podemos apreciar como cada vez más se buscan formas de ayuda para el desarrollo cotidiano por medio de las nuevas tecnologías, pues se han convertido en un elemento casi indispensable para gran parte de la población. [...]

Enginyeria Informàtica [958]  
1 p, 635.7 KB Proteomics in food safety / Bandrés Mériz, Julia ; Bassols Teixidó, Anna Maria, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Grau en Biologia [812]  
574 p, 7.3 MB La gestión de la seguridad integral en los centros educativos : facilitadores y obstaculizadores / Díaz Vicario, Anna ; Gairín Sallán, Joaquín, dir. (Universitat Autònoma de Barcelona. Departament de Pedagogia Aplicada) ; Universitat Autònoma de Barcelona. Departament de Pedagogia Aplicada
Los centros educativos deben ser espacios seguros tanto para el alumnado como para el personal docente y no docente. Cabe gestionar adecuadamente la seguridad para evitar que ocurran accidentes e incidentes, creando un entorno en el que se promueva el bienestar físico, emocional y social, individual y colectivo. [...]
Educational institutions must be safe and secure spaces for students and teachers and non-teaching staff. It should properly manage the safety and security to prevent accidents and incidents, creating an environment in which the physical, emotional, social, individual and collective well-being is promoted. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
144 p, 2.5 MB The life of nanoparticles in contact with biological media and entities / Tran Thi Thanh, Ngoc ; Puntes, Víctor F., dir. ; Pascual i Gainza, Jordi ; Universitat Autònoma de Barcelona. Departament de Física
Para contribuir al creciente requerimiento de una caracterización rigurosa de los materiales utilizados en el campo de nanotoxicología, el estudio de los problemas de toxicidad y seguridad de los nanomateriales, esta tesis tiene como objetivo describir la evolución de la identidad de las nanopartículas (capítulos 2 y 3), centrándose en la plata, un material muy comercializado, cuando se expone a entornos biológicos. [...]
Contributing to an increasing requirement of strict material characterization in the field of nanotoxicology, the study of toxicity and safety issues of nanomaterials, this thesis dissertation aims at describing the evolution of the identity of nanoparticles (chapters 2 and 3), focusing on silver, a highly commercialized material, when they are exposed to biological environments. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
35 p, 218.3 KB Exploring Determinants of Urban Motorcycle Accident Severity : The Case of Barcelona / Albalate del Sol, Daniel, 1980- (Universitat de Barcelona) ; Fernández Villadangos, Laura (Universitat de Barcelona) ; Xarxa de Referència en Economia Aplicada (XREAP)
Public authorities and road users alike are increasingly concerned by recent trends in road safety outcomes in Barcelona, which is the European city with the highest number of registered Powered Two-Wheel (PTW) vehicles per inhabitant,. [...]
Xarxa de Referència en Economia Aplicada (XREAP) 2009 (XREAP ; 2009-2)  

Research literature : 12 records found   1 - 10next  jump to record:
Personal and institutional archives 3 records found  
1 p, 230.3 KB Carta de Màrius Rubiralta, Vice-rector de Recerca de la UB, a Pere Pascual convidant-lo a l'acte d'inauguració del II European Forum on Science and Safety / Universitat de Barcelona.Vice-rectorat de Recerca
14 novembre 1994  
 UAB restricted access
1 p, 192.1 KB Carta de Pere Pascual a Antoni Caparrós i Benedicto, Rector de la UB, sobre la seva participació al II European Forum on Science and Safety / Pascual, Pedro, 1934-2006
20 setembre 1994  
 UAB restricted access
1 p, 300.9 KB Carta d'Antoni Caparrós i Benedicto, Rector de la UB, a Pere Pascual sobre la participació d'aquest al II European Forum on Science and Safety / Universitat de Barcelona. Rectorat
7 setembre 1994  
 UAB restricted access

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.